NEKTAR THERAPEUTICS Annual Net Cash Provided by (Used in) Financing Activities in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Nektar Therapeutics quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2023.
  • Nektar Therapeutics Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $42M.
  • Nektar Therapeutics annual Net Cash Provided by (Used in) Financing Activities for 2023 was $30K.
  • Nektar Therapeutics annual Net Cash Provided by (Used in) Financing Activities for 2022 was $1.51M, a 95.8% decline from 2021.
  • Nektar Therapeutics annual Net Cash Provided by (Used in) Financing Activities for 2021 was $36.2M.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $30K* -$1.48M Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
2022 $1.51M -$34.7M -95.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 $36.2M +$117M Jan 1, 2021 Dec 31, 2021 10-K 2024-03-05
2020 -$80.4M -$104M -444% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $23.4M -$829M -97.3% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $852M +$798M +1466% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 $54.4M -$149M -73.3% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-28
2016 $204M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2013 $2.22M -$24.6M -91.7% Jan 1, 2013 Dec 31, 2013 10-K 2014-02-27
2012 $26.8M -$196M -87.9% Jan 1, 2012 Dec 31, 2012 10-K 2014-02-27
2011 $222M +$215M +2851% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-27
2010 $7.54M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.